Statistics

Total Visits

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial93

Select a period of time:

Number of views in the range

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial29

Views

Views
December 20251
January 20260
February 20260
March 20261
April 20263
May 20267
June 202617
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
Netherlands5
Colombia2
United Kingdom2
Argentina2
Costa Rica1
Portugal1
Singapore1
Tunisia1
Turkey1
 

Top cities views

Views
Groningen4
Ashburn1
Bogotá1
Brooklyn1
Buffalo1
Gilbert1
Grants Pass1
Istanbul1
Koudekerke1
Milwaukee1